Cullinan Oncology
Science That Moves
Cambridge, United States · Founded 2016 · $150.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- cullinanoncology.com
- Total Funding
- $150.0M
- Last Round
- $150.0M Series AOct 2017
- Rounds
- 1
About
Cullinan Therapeutics develops high-impact, differentiated therapies for people living with autoimmune diseases and cancer. The company's clinical-stage pipeline reflects a deliberate approach of advancing only the most promising molecules to address high unmet needs. Cullinan unites scientific expertise, strategic risk-taking, and rigorous decision-making to accelerate immune-modulating therapies so patients spend less time managing their conditions and more time on what matters most.
Summary
Cullinan Oncology is a Biotech company based in Cambridge, United States, founded in 2016. It has raised $150.0M in total across 1 round, most recently a $150.0M Series A round in Oct 2017. Investors include F2 Ventures.
Funding History
Oct 2017
Investors
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cullinan-oncology"><img src="https://indexed.vc/api/badge/company/cullinan-oncology" alt="Cullinan Oncology on Indexed.vc" width="260" height="76" /></a>